Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Erbitux
Pharma
Sandoz, Henlius agree to $322M deal for 3 biosimilars
Sandoz has collaborated with Henlius to gain commercialization rights to three biosimilars for $100.5M up front and $322M if milestones are reached.
Kevin Dunleavy
Aug 17, 2026 10:46am
Merck KGaA tweaks 2025 forecast as geopolitical concerns mount
May 15, 2025 1:20pm
Merck KGaA, analysts share optimism about potential CDMO rebound
Aug 7, 2024 3:13pm
Opdivo-Yervoy, Bavencio fail in head and neck cancer
Sep 20, 2021 7:30am
Pfizer scores FDA nod for Braftovi duo in colon cancer
Apr 9, 2020 11:28am
Array's 'compelling' colon cancer data spark blockbuster talk
May 22, 2019 11:13am
